ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Innovation Pharmaceuticals Inc (CE)

Innovation Pharmaceuticals Inc (CE) (IPIX)

0.0001
0.00
(0.00%)
Cerrado 24 Enero 3:00PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
0.0001
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
90,500
0.0001 Rango del Día 0.0001
0.000001 Rango de 52 semanas 0.0195
Capitalización de Mercado [m]
Precio Anterior
0.0001
Precio de Apertura
0.0001
Última hora de negociación
Volumen financiero
US$ 9
Precio Promedio Ponderado
0.0001
Volumen promedio (3 m)
322,932
Acciones en circulación
518,347,691
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
-0.01
turnover
-
Beneficio neto
-3.17M

Acerca de Innovation Pharmaceuticals Inc (CE)

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Carson City, Nevada, USA
Fundado
-
Innovation Pharmaceuticals Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker IPIX. The last closing price for Innovation Pharmaceuticals (CE) was US$0. Over the last year, Innovation Pharmaceuticals (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.0195.

Innovation Pharmaceuticals (CE) currently has 518,347,691 shares in issue. The market capitalisation of Innovation Pharmaceuticals (CE) is US$51,834.77 . Innovation Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of 0.00.

IPIX Últimas noticias

IQST Has Catalysts On Deck That Expose A Valuation Disconnect of Roughly 100% - Here's Why That Gap Should Close

November 5, 2021 -- InvestorsHub NewsWire -- via Hawk Point Media -- Benzinga iQSTEL Inc.’s (OTCQX:IQST) market cap of $62M is absurdly low. In fact, 2021 revenues, if they...

CEO Presenting on the Emerging Growth Conference on October 13 Register Now

CEO Presenting on the Emerging Growth Conference on October 13 Register Now Niche Companies in Technology, Biotech / Pharma, FinTech, Exploration, Wellness, and more in Attendance. Miami, Florida...

CEO's Presenting on the Emerging Growth Conference 17 TODAY.  Register Now

CEO's Presenting on the Emerging Growth Conference 17 TODAY.  Register Now   Niche Companies in Technology, Biotech / Pharma, FinTech, Exploration, Wellness, and more in...

CLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% Growth

CLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% Growth   Miami, FL--(September 28, 2021) – EmergingGrowth.com, a leading independent small cap media portal...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.00010.00010.0001145070.0001CS
4000.00010.00030.00012267390.0001CS
12-0.0003-750.00040.01870.00013229320.00019707CS
26-0.0011-91.66666666670.00120.01871.0E-62908150.00035374CS
52-0.0099-990.010.01951.0E-63162560.00526119CS
156-0.0369-99.72972972970.0370.06491.0E-65037170.02125376CS
260-0.0799-99.8750.080.651.0E-612799540.16982493CS

IPIX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Innovation Pharmaceuticals (CE)?
El precio actual de las acciones de Innovation Pharmaceuticals (CE) es US$ 0.0001
¿Cuántas acciones de Innovation Pharmaceuticals (CE) están en circulación?
Innovation Pharmaceuticals (CE) tiene 518,347,691 acciones en circulación
¿Cuál es la capitalización de mercado de Innovation Pharmaceuticals (CE)?
La capitalización de mercado de Innovation Pharmaceuticals (CE) es USD 51.83k
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Innovation Pharmaceuticals (CE)?
Innovation Pharmaceuticals (CE) ha negociado en un rango de US$ 0.000001 a US$ 0.0195 durante el último año
¿Cuál es la moneda de reporte de Innovation Pharmaceuticals (CE)?
Innovation Pharmaceuticals (CE) presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Innovation Pharmaceuticals (CE)?
El último beneficio anual de Innovation Pharmaceuticals (CE) es USD -3.17M
¿Cuál es la dirección registrada de Innovation Pharmaceuticals (CE)?
La dirección registrada de Innovation Pharmaceuticals (CE) es 701 S. CARSON STREET, SUITE 200, CARSON CITY, NEVADA, 89701
¿Cuál es la dirección del sitio web de Innovation Pharmaceuticals (CE)?
La dirección del sitio web de Innovation Pharmaceuticals (CE) es www.ipharminc.com
¿En qué sector industrial opera Innovation Pharmaceuticals (CE)?
Innovation Pharmaceuticals (CE) opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MITJFMint Corporation (CE)
US$ 0.01
(999,900.00%)
1.5k
SPECSpectaire Holdings Inc (CE)
US$ 0.001
(99,900.00%)
3.4k
AWINAERWINS Technologies Inc (CE)
US$ 0.0003
(29,900.00%)
809
MHPCManufactured Housing Properties Inc (CE)
US$ 0.0003
(29,900.00%)
800
GNRSQGreenrose Holding Company Inc (CE)
US$ 0.02
(19,900.00%)
10.2k
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.000001
(-99.99%)
539
PKLBFPerk Labs Inc (CE)
US$ 0.000001
(-99.97%)
104.66k
EVRRFMolecule Holdings Inc (CE)
US$ 0.000001
(-99.96%)
30.58k
SEELQSeelos Therapeutics Inc (CE)
US$ 0.0001
(-99.94%)
284
ELYSElys BMG Group Inc (CE)
US$ 0.000001
(-99.75%)
895
HMBLHUMBL Inc (PK)
US$ 0.0008
(0.00%)
254.92M
MMEXMMEX Resources Corporation (PK)
US$ 0.0001
(0.00%)
205.15M
GTVHGolden Triangle Ventures Inc (PK)
US$ 0.0003
(0.00%)
127.06M
RONNRonn Motor Group Inc (PK)
US$ 0.0003
(-25.00%)
114.93M
PDGOParadigm Oil and Gas Inc (PK)
US$ 0.0001
(0.00%)
111.05M

IPIX Discussion

Ver más
sunspotter sunspotter 5 horas hace
“ Are IPIX shareholders destined to lose our control over Brilicidin?”

Best as I can gauge, IPIX shareholders never had any control over IPIX.

Leo Ehrlich long neglected his fiduciary and other responsible governance responsibilities to his investors ( or “marks” as he and Mr. Bean invariably refer to you). more recently he has also decided to ignore his legal responsibilities under US Securities Laws.
👍️0
george h george h 6 horas hace
Are IPIX shareholders destined to lose our control over Brilicidin the same way we got it; through a bargain basement bankruptcy auction?
gh
👍️0
loanranger loanranger 8 horas hace
Attorney Dwyer gave them to me. Gave them to everybody. If only you knew where to look.

It's little wonder that some people hold these shares.
👍️ 1
leavetheguntakethecannolis leavetheguntakethecannolis 8 horas hace
When exactly did you gain access to IPIX emails?
👍️0
loanranger loanranger 9 horas hace
Unbelievable.
Leo never "sent the mail" and Dwyer took the case in January of 2020.
👍️0
PJ007 PJ007 18 horas hace
I'm sure if Dwyer is taking the case, Leo had sent the mail.....
👍 2
realscottsmith realscottsmith 18 horas hace
Could be they argued Leo thought he sent Cummings an email but it got stuck in the "draft" menu.
👍️0
Pipilongstocking Pipilongstocking 18 horas hace
Did Leo send an email at the time?
👍️0
loanranger loanranger 20 horas hace
It's too bad that the Appeals Court doesn't provide a .pdf of their docket items the way the lower court does. I'd like to know how IPIX responded.
👍️ 1
Cassius Longinus Cassius Longinus 1 día hace
Reply brief filed for Innovation Pharmaceuticals Inc. by Attorney Daniel Dwyer.
👍 5
loanranger loanranger 2 días hace
"after a lengthy pause due to the Israel war with Hamas". Sez you. If Ehrlich thought he could sell that story we would have heard it before YOU told it.
Or maybe BeaMed made an announcement to that effect and I missed it. Did they?
👍️ 1 💤 1
MackG MackG 2 días hace
Hi, Pete. Good to see your post. I agree with you that we need a "white hat" company to carry the ball from here, and it looks like our best hope is our investment in BeaMed Pharma and their StingRay laser system, which, after after a lengthy pause due to the Israel war with Hamas, has begun to move forward as demonstrated by two recent hires. Our potential there is big, along with Brilacidin. I still hold out hope.
👍️ 5
loanranger loanranger 2 días hace
Virtually identical! Except for the no email part.
👍️0
Cassius Longinus Cassius Longinus 2 días hace
You are correct. It just all seemed so similar to the Innovation case. I should have read more carefully!
👍️0
loanranger loanranger 2 días hace
"So Leo did provide notice to Cummins before the renewal date, albeit through email, which was not an approved means."
IPIX sent no such email and the article doesn't say that it did.

The case(s) referred to in the article involved leases with similar if not identical terms regarding the notice requirements regarding automatic renewal and in one case the Judge ruled that, even though the lease explicitly precluded email as a proper method of communication, he decided as the article headline states: "Email to landlord was sufficient written notice of nonrenewal".

The Exhibit List in the IPIX/Cummins case does not include an email from anyone at IPIX during the option period indicating that there was no intention to renew the lease. It seems obvious then that even if the current Judge was inclined to accept email as an acceptable form of communication it wouldn't matter at all.

This case and the case(s) in the cited article are different in the most critical of elements.

Note from current Appeals Court Docket:
11/26/2024 #19 Motion of Appellant to extend date for filing Reply Brief filed for Innovation Pharmaceuticals Inc. by Attorney Daniel Dwyer.
11/26/2024 RE#19: Allowed to 1/19/25. *Notice.
👍️0
loanranger loanranger 2 días hace
The article that you linked is not the complete article, which can be seen here:
https://masslawyersweekly.com/2023/06/12/email-to-landlord-was-sufficient-written-notice-of-nonrenewal/?utm_term=Email%20to%20landlord%20was%20sufficient%20written%20notice%20of%20nonrenewal&utm_campaign=Email%20to%20landlord%20was%20sufficient%20written%20notice%20of%20nonrenewal&utm_content=Editorial&utm_source=Act-On+Software&utm_medium=MALW&Email=ddwyer@verrill-law.com

The article makes no mention at all of Innovation Pharmaceuticals.
The thing that IPIX and the other plaintiffs had in common were the terms of the lease and the lease extension.
(See response to subsequent post.)
👍️0
leavetheguntakethecannolis leavetheguntakethecannolis 2 días hace
And the ubiquitous psyop continues...........
👍️0
Cassius Longinus Cassius Longinus 2 días hace
So Leo did provide notice to Cummins before the renewal date, albeit through email, which was not an approved means. The appeals court does not agree with Cummins according to the article.
👍️ 5
Cassius Longinus Cassius Longinus 2 días hace
Found this on the lawyers website:
Partner Daniel J. Dwyer was recently quoted in Massachusetts Lawyers Weekly article, “Email to landlord was sufficient written notice of nonrenewal”. The article discusses the recent ruling from the Massachusetts Appeals Court stating an e-mail by which a commercial tenant notifies its landlord that the lease will not automatically renew suffices as notice of non-renewal, even in a lease stating that e-mail notice is not effective.

In 2018, Dwyer won a similar trial against the same landlord, Cummings Properties LLC, and the verdict was affirmed on appeal. He believes that the Appeals Court has” had it” with Cummings Properties’ treatment of its commercial tenants. He went on to say that the Appeals Court, “knows that the automatic extension cases it sees represent just a fraction of the times that,” according to the trial judge in the recent case, Cummings, on receipt of notice, ”covers its ears like a child unwilling to listen to a piece of unwelcome information” in order to cause an automatic lease renewal to occur and thereby to deliver a devastating financial shock to one of its tenants.
👍️ 9
thttlpckg thttlpckg 3 días hace
Did you get in on that trump meme coin?
Cuz that's definitely not a scam.
👍️ 1
petemantx petemantx 3 días hace
Chilling to me that I now consider Leo in the same light as I view Biden; wouldn't trust either of them. DC got a major do-over, hope that IPIX gets the same (but then who would come to IPIX right now). It seems both have been more caring about their own fortunes than those of the public/shareholders for whom they were supposed to be working. The current rental lawsuit was the final slap in the face considering that IPIX hasn't had more than two employees (1 maybe who ever went to the office) and no need for a lab for over 10 years now and yet Leo felt we needed to lease such space. Still believe in B but IMO some white hat is going to have to come in to pick up the ball (currently deflated) and run with it.
👍 1
sunspotter sunspotter 3 días hace
"its nice to see that you are still on part-time status......"

We know that's not true, but what is true is that the victims of penny stock scam IPIX and grifter Leo Ehrlich have had to take extra jobs to make up for their heavy losses, alimony payments ("you speculated on WHAT??") and frittered away college funds.......................
👍️0
PJ007 PJ007 3 días hace
Thank you for the update mr. loan...its nice to see that you are still on part-time status......
👍️ 1
loanranger loanranger 3 días hace
Recent IPIX News
Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
👍️0
PJ007 PJ007 3 días hace
It's so nice to see tat the alumni keep coming back to visit.....
👍️0
MackG MackG 3 días hace
After 5 years of silence you wanted to post a message so that we know you are selling your shares. So very thoughtful of you.
👍️ 1
leavetheguntakethecannolis leavetheguntakethecannolis 3 días hace
https://www.ipharminc.com/press-release/2023/8/27/innovation-pharmaceuticals-announces-new-milestone-at-beamed-on-track-to-file-510k-submission-to-fda-in-q2-2024

BeaMed is on track to submit, in Q2 2024, the System for potential FDA approval via the 510(k) regulatory pathway.

“BeaMed remains steadfast in its commitment to help patients suffering from current gaps in care,” said Gil Shapira, Co-Founder of BeaMed. “Our goal with the StingRay system is to commercialize a novel technology to treat previous inoperable cases of epilepsy and improve outcomes in other surgical-based oncology procedures. It’s exciting to think that in approximately one year this may be a reality.”

Tic Tok
👍️ 3
loanranger loanranger 4 días hace
Has anyone heard from Leo? His long silence has not been appreciated.
😂 1
sunspotter sunspotter 5 días hace
Excellent call!

You certainly taught those worry warts a lesson!

🤣
👍️0
TheHound TheHound 5 días hace
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173175948
👍️0
Swish22 Swish22 5 días hace
Haven't checked in here in over 5 years. On a whim decided to check out the old forum I used to spend much time on back in the day. Honestly surprised there are still posts here. 

 I was very interested in this as we were told there were several drugs in the pipeline at various phases. Some in or near phase3 with potential for big partners. I still hold and will finally sell to offset gains for tax purposes. I accepted we were being strung along several years back.

Good luck everyone. 
👍️0
TheHound TheHound 6 días hace
IPIX is dead.
👍️0
sunspotter sunspotter 1 semana hace
I'm flattered, but I assure you I'm not loanranger.

I'm not even Tonto, just a semi-retired Pharma Corner Office Executive who knows a penny stock scam when he sees one.
👍️ 1
leavetheguntakethecannolis leavetheguntakethecannolis 1 semana hace
Thank you Mr. Loan
👍️ 1
sunspotter sunspotter 1 semana hace
Some sage advice from the estimable @Renee

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175657015
👍️ 2
loanranger loanranger 1 semana hace
Brush up on your reading.
"They can't sell them, lend them or use them as security. Hence they are currently worthless to IPIX. "
👍️ 1
leavetheguntakethecannolis leavetheguntakethecannolis 1 semana hace
Thank you for helping to dispel the misinformation purported here on a daily basis.
👍️ 3
PJ007 PJ007 2 semanas hace
They have no choice but to wait....the lien will obviously accrue daily interest....It would be advantageous for Leo to pay it sooner than later. In my opinion, he should pay it with his own funds since it was his F up!!!!!
👍️ 3
thttlpckg thttlpckg 2 semanas hace
If appeal fails, won't they owe right away? Doubt plaintiff will wait for IPIX to succeed/fail.
👍️ 1
PJ007 PJ007 2 semanas hace
They are not worthless.....if the company succeeds and the share price of IPIX goes up, Leo can sell IPIX shares and pay off his debt to Cummins and the court will release the lien. Thats how liens work......
👍️ 3
loanranger loanranger 2 semanas hace
As you quoted "On June 9, 2022, Innovation Pharmaceuticals Inc. (the “Company”) entered into a Series A Preferred Share Purchase Agreement (the “Purchase Agreement”) with Squalus Med Ltd., a company established under the laws of the State of Israel (“SML”), pursuant to which the Company purchased 55,556 shares of SML’s Series A Redeemable Preferred Shares (the “Series A Shares”)"....
....and it is those shares that are now useless to IPIX. They can't sell them, lend them or use them as security. Hence they are currently worthless to IPIX.

Shareholders of the Company need to know that.
👍️ 1
realscottsmith realscottsmith 2 semanas hace
There is no laser, there never was a laser, as far as ipix shareholders are concerned. 
👍️ 1
MackG MackG 2 semanas hace
IPIX purchased and still owns a substantial interest in BeaMed according to a prior IPIX announcement in 2022:
INNOVATION PHARMACEUTICALS, INC. BOUGHT 41.6 % OF SQUALUS MED, LTD. (NOW BT BeaMed Technologies)
IPIX has bought a sizable stake in an Israeli company that has a novel laser ablation technology, Squalus Medical, Ltd. (now, BT BeaMed Technologies.

Per new 8k- Item 1.01 Entry into a Material Definitive Agreement.

On June 9, 2022, Innovation Pharmaceuticals Inc. (the “Company”) entered into a Series A Preferred Share Purchase Agreement (the “Purchase Agreement”) with Squalus Med Ltd., a company established under the laws of the State of Israel (“SML”), pursuant to which the Company purchased 55,556 shares of SML’s Series A Redeemable Preferred Shares (the “Series A Shares”) and a warrant (the “Warrant”) to purchase 27,778 Series A Shares for aggregate consideration of $4,000,000, or approximately $72.00 per Series A Share. Following the closing under the Purchase Agreement, the Company owns approximately 35.7% of SML’s issued and outstanding equity securities and approximately 41.6% of SML’s equity securities on a fully diluted basis. The Company also entered into customary investor rights and indemnification agreements with SML." IMO, There is every reason to believe based on news of recent BeaMed hires that things are moving forward with the amazing StingRay Laser System.
👍️ 4 💲 2
PJ007 PJ007 2 semanas hace
He's been put on part time status!!!!!
👍️ 1
leavetheguntakethecannolis leavetheguntakethecannolis 2 semanas hace
4 days does seem like a long time to wait for a response. Especially when it's the same poster.
👍️ 1
leavetheguntakethecannolis leavetheguntakethecannolis 2 semanas hace
4 million does not equal 1.4 million and 1.4 million does not equal 4 million. Only in agenda driven mathematics is this the case.
👍️ 1
TheHound TheHound 2 semanas hace
So yea IPIX does have a stake in BeaMed. A big one

IPIX is dead. The company stopped reporting. That means ur fucked.
👍️0
loanranger loanranger 2 semanas hace
"IPIX put that asset up security, but continues to own their interest in BeaMed. It is worth far more in future earnings than 1.4M."
They lost their case and as a result were REQUIRED to post the only asset they had that could act as security for the judgment. It is now USELESS to them. Do you really expect them to win their appeal? Do you know what happens if/when they don't?

In 2020 a poster noted that Leo/IPIX was stiffing Menon and Cummings. You said ""Stiffing" these individuals carries the accusation that Leo NEVER INTENDS TO PAY THEM. We are well aware of these liabilities. But without evidence that they will never be paid, it's BULLSH-T."
I guess it's too soon to call it never, but it is 4 years+ later and both parties remain stiffed.

Wrong for 8 years and counting:
"Incredible prospects for a super cheap stock! I am adding."
(your first post)
👍️ 1
snayeman snayeman 2 semanas hace
Does anyone even know what’s going on with the laser as far as production etc
👍️0
cantwate cantwate 2 semanas hace
Funny how Mr. Know it all Sunspotter NEVER responded to my post.
He always has some response. After all he has over 50 years of KNOWITALL experience..
He had to wait for LoanRanger to get back in to the office 4 days later to help him out.
BTW IPIX has a $4,000,000 stake in BeaMed and so Cummings(owed a little over $1m) would be entitled to a fraction of the shares once the Laser gets approved.
So yea IPIX does have a stake in BeaMed. A big one.
👍️ 5 💯 1

Su Consulta Reciente

Delayed Upgrade Clock